Hepatitis B Surface Antigen and Hepatitis C Antibody Seroprevalence Among Male Blood Donors in Lahore, Pakistan: A Cross-Sectional Study at Four Blood Banks

Authors

  • Muskan Naseer Department of Microbiology, Faculty of Biological Sciences, Superior University, Lahore, Punjab, Pakistan
  • Farzand Ali Department of Hematology and Blood Bank, Shaikh Zayed Medical Complex, Lahore, Punjab, Pakistan
  • Malaika Jameel Butt Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Punjab, Pakistan
  • Amna Tariq Punjab Thalassemia and other Genetic Disorders Prevention and Research Institute, Lahore, Punjab, Pakistan
  • Muhammad Salman Department of Medical Laboratory Technology, Faculty of Allied Health Sciences, Superior University, Lahore, Punjab, Pakistan

DOI:

https://doi.org/10.64813/ejmr.2026.136

Keywords:

Blood Donors, HbsAg, anti-HCV, Seroepidemiologic, ABO blood-grouping, Pakistan

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) pose important challenges to blood safety, highlighting the need for continued surveillance among blood donors. This cross-sectional study assessed the seroprevalence of hepatitis B surface antigen (HBsAg) and anti-HCV antibodies among male blood donors at four blood banks in Lahore, Pakistan, and examined their associations with age and ABO/Rh blood group. A total of 600 donors were included, with 150 recruited from each of General Hospital Lahore, Services Hospital Lahore, Noor Thalassaemia Centre, and Zaib Ali Foundation. Serum samples were screened using immunochromatographic rapid tests. Seroprevalence estimates were calculated with 95% Wilson confidence intervals (CIs). Associations with blood group were assessed using chi-square tests, and age distributions were compared using the Mann–Whitney U test. Statistical significance was defined as a two-sided p < 0.05. HBsAg seroprevalence was 4.8% (29/600; 95% CI, 3.4–6.9%), and anti-HCV seroprevalence was 4.5% (27/600; 95% CI, 3.1–6.5%). B-positive was the most frequent blood group (33.0%). Neither HBsAg nor anti-HCV reactivity was significantly associated with ABO/Rh blood group (χ² = 10.17, p = 0.179 and χ² = 4.16, p = 0.762, respectively). Age distributions did not differ significantly between reactive and nonreactive donors for either marker (p = 0.210 and p = 0.922, respectively). No significant association was observed between HBsAg and anti-HCV reactivity (p = 0.858). Approximately one in twenty donors screened reactive for each marker, underscoring the importance of reliable donor screening, appropriate confirmatory testing, donor counselling and referral. These findings represent screening-marker seroprevalence rather than confirmed active infection and should be interpreted within the limitations of rapid testing and the sampled male donor population.

Downloads

Published

17-10-2026

Issue

Section

Research article

How to Cite

Naseer, M., Ali, F., Butt, M. J., Tariq, A., & Salman, M. (2026). Hepatitis B Surface Antigen and Hepatitis C Antibody Seroprevalence Among Male Blood Donors in Lahore, Pakistan: A Cross-Sectional Study at Four Blood Banks. Electronic Journal of Medical Research, 2(4), 1-9. https://doi.org/10.64813/ejmr.2026.136

Most read articles by the same author(s)

Similar Articles

21-21 of 21

You may also start an advanced similarity search for this article.